Summit Therapeutics (SMMT)

Summit Therapeutics (SMMT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• SMMT last traded at $15.02, -6.30% on the day.
• Summit Therapeutics: market cap $12.79B, P/E -14.2, next earnings 2026-11-02.
• Over the past year SMMT returned -19.42%; year to date -14.12%.

Updated 2026-11-02 18:24 UTC